Wang J Q, McGinty J F
Department of Anatomy and Cell Biology, East Carolina University School of Medicine, Greenville, North Carolina 27858-4354, USA.
Brain Res Bull. 1996;39(6):349-57. doi: 10.1016/0361-9230(96)00002-0.
This study tested the role of N-methyl-D-aspartate and kainate/AMPA receptors in mediating mRNA expression of the immediate early gene zif/268 and the opioid peptide genes preprodynorphin and preproenkephalin in rat forebrain following a single injection of methamphetamine. At 3 h after acute methamphetamine [4 mg/kg, intraperitoneally (IP)], quantitative in situ hybridization histochemistry revealed that zif/268 mRNA expression was increased in the dorsal striatum (caudoputamen) and in the sensory cortex. Preprodynorphin was increased in both dorsal and ventral striatum (nucleus accumbens) and preproenkephalin was increased in the dorsal striatum. Pretreatment with (+ or -)-3-(2-carboxypiperazin-4-yl)-propyl-1 -phosphonic acid (CPP) (10 mg/kg, IP), an N-methyl-D-aspartate receptor antagonist, blocked the methamphetamine-induced zif/268 mRNA expression in the striatum and in the region of sensory cortex representing the upper limb and nose. 6,7-Dinitro-quinoxaline-2,3-dione (DNQX) (100 mg/kg, IP), a kainate/AMPA receptor antagonist, did not reduce the ability of methamphetamine to induce zif/268 mRNA in striatal and cortical neurons. Furthermore, both antagonists caused a parallel blockade of methamphetamine-stimulated preprodynorphin mRNA expression in the dorsal and ventral striatum but did not significantly affect methamphetamine-stimulated preproenkephalin mRNA expression. CPP and DNQX reduced basal levels of zif/268 mRNA in cortical and striatal neurons but did not affect the constitutive expression of the two opioid mRNAs in the striatum. Neither antagonist had a significant effect on methamphetamine-induced hyperlocomotion and stereotypies. These results demonstrate that both N-methyl-D-aspartate and kainate/AMPA receptor-mediated glutamatergic transmission is linked to modulation of the methamphetamine-stimulated oploid peptide gene expression in rat forebrain. Furthermore, N-methyl-D-aspartate receptors participate in methamphetamine-stimulated zif/268 expression.
本研究检测了N-甲基-D-天冬氨酸(N-methyl-D-aspartate)和海人藻酸/α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(kainate/AMPA)受体在单次注射甲基苯丙胺后介导大鼠前脑即刻早期基因zif/268以及阿片肽基因前强啡肽原和前脑啡肽原mRNA表达中的作用。急性注射甲基苯丙胺[4毫克/千克,腹腔注射(IP)]后3小时,定量原位杂交组织化学显示,zif/268 mRNA表达在背侧纹状体(尾壳核)和感觉皮层中增加。前强啡肽原在背侧和腹侧纹状体(伏隔核)中均增加,前脑啡肽原在背侧纹状体中增加。用N-甲基-D-天冬氨酸受体拮抗剂(±)-3-(2-羧基哌嗪-4-基)-丙基-1-磷酸(CPP)(10毫克/千克,腹腔注射)预处理,可阻断甲基苯丙胺诱导的纹状体和代表上肢及鼻部的感觉皮层区域的zif/268 mRNA表达。海人藻酸/AMPA受体拮抗剂6,7-二硝基喹喔啉-2,3-二酮(DNQX)(100毫克/千克,腹腔注射)并未降低甲基苯丙胺诱导纹状体和皮层神经元中zif/268 mRNA的能力。此外,两种拮抗剂均能平行阻断甲基苯丙胺刺激的背侧和腹侧纹状体中前强啡肽原mRNA表达,但对甲基苯丙胺刺激的前脑啡肽原mRNA表达无显著影响。CPP和DNQX降低了皮层和纹状体神经元中zif/268 mRNA的基础水平,但不影响纹状体中两种阿片类mRNA的组成性表达。两种拮抗剂对甲基苯丙胺诱导的运动亢进和刻板行为均无显著影响。这些结果表明,N-甲基-D-天冬氨酸和海人藻酸/AMPA受体介导的谷氨酸能传递均与甲基苯丙胺刺激的大鼠前脑阿片肽基因表达的调节有关。此外,N-甲基-D-天冬氨酸受体参与了甲基苯丙胺刺激的zif/268表达。